Search

Bharati R Dhruva

Examiner (ID: 3913)

Most Active Art Unit
1632
Art Unit(s)
1632
Total Applications
2
Issued Applications
1
Pending Applications
1
Abandoned Applications
0

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 7503601 [patent_doc_number] => 08034791 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-10-11 [patent_title] => 'Activation of Egr-1 promoter by DNA damaging chemotherapeutics' [patent_app_type] => utility [patent_app_number] => 11/467799 [patent_app_country] => US [patent_app_date] => 2006-08-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 26 [patent_no_of_words] => 11703 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 68 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/034/08034791.pdf [firstpage_image] =>[orig_patent_app_number] => 11467799 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/467799
Activation of Egr-1 promoter by DNA damaging chemotherapeutics Aug 27, 2006 Issued
Array ( [id] => 9085864 [patent_doc_number] => 08557289 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-10-15 [patent_title] => 'Nanoparticle suitable for delivery of a biomolecule into or out of a membrane enclosed cell or cell organelle' [patent_app_type] => utility [patent_app_number] => 11/990522 [patent_app_country] => US [patent_app_date] => 2006-08-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 5575 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 285 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11990522 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/990522
Nanoparticle suitable for delivery of a biomolecule into or out of a membrane enclosed cell or cell organelle Aug 20, 2006 Issued
Array ( [id] => 5889903 [patent_doc_number] => 20060276427 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-12-07 [patent_title] => 'Regulation of endogenous gene expression in cells using zinc finger proteins' [patent_app_type] => utility [patent_app_number] => 11/505044 [patent_app_country] => US [patent_app_date] => 2006-08-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 29868 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0276/20060276427.pdf [firstpage_image] =>[orig_patent_app_number] => 11505044 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/505044
Repressing endogenous CCR5 gene expression in cells using engineered zinc finger proteins Aug 15, 2006 Issued
Array ( [id] => 5153891 [patent_doc_number] => 20070036774 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-02-15 [patent_title] => 'Liver engrafting cells, assays, and uses thereof' [patent_app_type] => utility [patent_app_number] => 11/502210 [patent_app_country] => US [patent_app_date] => 2006-08-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 13089 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0036/20070036774.pdf [firstpage_image] =>[orig_patent_app_number] => 11502210 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/502210
Human liver engrafting cells isolated from adult liver tissue Aug 8, 2006 Issued
Array ( [id] => 5836774 [patent_doc_number] => 20060248606 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-02 [patent_title] => 'Mouse model for hepatitis C' [patent_app_type] => utility [patent_app_number] => 11/480012 [patent_app_country] => US [patent_app_date] => 2006-06-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 5011 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0248/20060248606.pdf [firstpage_image] =>[orig_patent_app_number] => 11480012 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/480012
Mouse model for hepatitis C Jun 28, 2006 Abandoned
Array ( [id] => 5921286 [patent_doc_number] => 20060239975 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-10-26 [patent_title] => 'Methods for treating cancers and restenosis with p21' [patent_app_type] => utility [patent_app_number] => 11/475827 [patent_app_country] => US [patent_app_date] => 2006-06-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 5969 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0239/20060239975.pdf [firstpage_image] =>[orig_patent_app_number] => 11475827 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/475827
Methods for treating cancers and restenosis with p21 Jun 26, 2006 Abandoned
Array ( [id] => 12322521 [patent_doc_number] => 09943481 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-04-17 [patent_title] => Compositions and methods using same for delivering agents into a target organ protected by a blood barrier [patent_app_type] => utility [patent_app_number] => 11/921022 [patent_app_country] => US [patent_app_date] => 2006-05-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 12223 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 101 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11921022 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/921022
Compositions and methods using same for delivering agents into a target organ protected by a blood barrier May 24, 2006 Issued
Array ( [id] => 5236020 [patent_doc_number] => 20070128176 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-06-07 [patent_title] => 'Stem cells of the islets of langerhans and their use in treating diabetes mellitus' [patent_app_type] => utility [patent_app_number] => 11/438790 [patent_app_country] => US [patent_app_date] => 2006-05-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 32 [patent_no_of_words] => 25358 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0128/20070128176.pdf [firstpage_image] =>[orig_patent_app_number] => 11438790 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/438790
Stem cells of the islets of langerhans and their use in treating diabetes mellitus May 21, 2006 Issued
Array ( [id] => 5753607 [patent_doc_number] => 20060222756 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-10-05 [patent_title] => 'Medical devices, drug coatings and methods of maintaining the drug coatings thereon' [patent_app_type] => utility [patent_app_number] => 11/437572 [patent_app_country] => US [patent_app_date] => 2006-05-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 22061 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0222/20060222756.pdf [firstpage_image] =>[orig_patent_app_number] => 11437572 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/437572
Medical devices, drug coatings and methods of maintaining the drug coatings thereon May 18, 2006 Abandoned
Array ( [id] => 5290485 [patent_doc_number] => 20090023215 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-01-22 [patent_title] => 'Novel reagents for transfection of eukaryotic cells' [patent_app_type] => utility [patent_app_number] => 11/434765 [patent_app_country] => US [patent_app_date] => 2006-05-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 27011 [patent_no_of_claims] => 69 [patent_no_of_ind_claims] => 20 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0023/20090023215.pdf [firstpage_image] =>[orig_patent_app_number] => 11434765 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/434765
Reagents for transfection of eukaryotic cells May 16, 2006 Issued
Array ( [id] => 5704785 [patent_doc_number] => 20060193833 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-08-31 [patent_title] => 'Compositions for gene therapy of rheumatoid arthritis including a gene encoding an anti-angiogenic protein or parts thereof' [patent_app_type] => utility [patent_app_number] => 11/431526 [patent_app_country] => US [patent_app_date] => 2006-05-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 8175 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0193/20060193833.pdf [firstpage_image] =>[orig_patent_app_number] => 11431526 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/431526
Compositions for gene therapy of rheumatoid arthritis including a gene encoding an anti-angiogenic protein or parts thereof May 10, 2006 Abandoned
Array ( [id] => 5302940 [patent_doc_number] => 20090297592 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-03 [patent_title] => 'Lipid Vesicle Composition' [patent_app_type] => utility [patent_app_number] => 11/920094 [patent_app_country] => US [patent_app_date] => 2006-05-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 9753 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0297/20090297592.pdf [firstpage_image] =>[orig_patent_app_number] => 11920094 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/920094
Lipid Vesicle Composition May 10, 2006 Abandoned
Array ( [id] => 5682556 [patent_doc_number] => 20060198826 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-09-07 [patent_title] => 'Compositions for gene therapy of rheumatoid arthritis including a gene encoding an anti-angiogenic protein or parts thereof' [patent_app_type] => utility [patent_app_number] => 11/431663 [patent_app_country] => US [patent_app_date] => 2006-05-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 8174 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0198/20060198826.pdf [firstpage_image] =>[orig_patent_app_number] => 11431663 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/431663
Compositions for gene therapy of rheumatoid arthritis including a gene encoding an anti-angiogenic protein or parts thereof May 10, 2006 Abandoned
Array ( [id] => 4443253 [patent_doc_number] => 07862652 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-01-04 [patent_title] => 'Directional self-assembly of biological electrical interconnects' [patent_app_type] => utility [patent_app_number] => 11/418817 [patent_app_country] => US [patent_app_date] => 2006-05-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 9 [patent_no_of_words] => 17443 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 66 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/862/07862652.pdf [firstpage_image] =>[orig_patent_app_number] => 11418817 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/418817
Directional self-assembly of biological electrical interconnects May 3, 2006 Issued
Array ( [id] => 5290055 [patent_doc_number] => 20090022785 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-01-22 [patent_title] => 'Permeable Capsules' [patent_app_type] => utility [patent_app_number] => 11/913491 [patent_app_country] => US [patent_app_date] => 2006-05-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7269 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0022/20090022785.pdf [firstpage_image] =>[orig_patent_app_number] => 11913491 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/913491
Permeable Capsules May 2, 2006 Abandoned
Array ( [id] => 5834313 [patent_doc_number] => 20060246143 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-02 [patent_title] => 'Targeted therapy via targeted delivery of energy susceptible nanoscale magnetic particles' [patent_app_type] => utility [patent_app_number] => 11/410607 [patent_app_country] => US [patent_app_date] => 2006-04-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 10293 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0246/20060246143.pdf [firstpage_image] =>[orig_patent_app_number] => 11410607 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/410607
Targeted therapy via targeted delivery of energy susceptible nanoscale magnetic particles Apr 24, 2006 Abandoned
Array ( [id] => 5642725 [patent_doc_number] => 20060281180 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-12-14 [patent_title] => 'Vectors' [patent_app_type] => utility [patent_app_number] => 11/410669 [patent_app_country] => US [patent_app_date] => 2006-04-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 49 [patent_figures_cnt] => 49 [patent_no_of_words] => 17469 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0281/20060281180.pdf [firstpage_image] =>[orig_patent_app_number] => 11410669 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/410669
Vectors Apr 24, 2006 Abandoned
Array ( [id] => 4866356 [patent_doc_number] => 20080145415 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-06-19 [patent_title] => 'Bioresorbable Fillers Constituted by Phospholipid Liposomes and Hyaluronic Acid and/or the Derivatives Thereof' [patent_app_type] => utility [patent_app_number] => 11/920009 [patent_app_country] => US [patent_app_date] => 2006-04-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5647 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0145/20080145415.pdf [firstpage_image] =>[orig_patent_app_number] => 11920009 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/920009
Bioresorbable Fillers Constituted by Phospholipid Liposomes and Hyaluronic Acid and/or the Derivatives Thereof Apr 20, 2006 Abandoned
Array ( [id] => 4994664 [patent_doc_number] => 20070010009 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-01-11 [patent_title] => 'Antibody Composition-Producing Cell' [patent_app_type] => utility [patent_app_number] => 11/279748 [patent_app_country] => US [patent_app_date] => 2006-04-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 52 [patent_figures_cnt] => 52 [patent_no_of_words] => 77436 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0010/20070010009.pdf [firstpage_image] =>[orig_patent_app_number] => 11279748 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/279748
Antibody Composition-Producing Cell Apr 12, 2006 Abandoned
Array ( [id] => 10627629 [patent_doc_number] => 09345768 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-05-24 [patent_title] => 'Nanoparticle/active ingredient conjugates' [patent_app_type] => utility [patent_app_number] => 11/911196 [patent_app_country] => US [patent_app_date] => 2006-04-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8138 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 90 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11911196 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/911196
Nanoparticle/active ingredient conjugates Apr 11, 2006 Issued
Menu